2m 2m 2m 2m 2m 2m 2m
Voyager Therapeu (VYGR)
NASDAQ
$1.90-$0.12 (-6.19%)
Price as of Oct 22, 2026 7:54 PM EDT- $124.5MMarket Cap
- -57.65%1-Year Change
- BiotechnologyIndustry
Voyager Therapeu (VYGR)
$1.90-$0.12 (-6.19%)
VYGR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.02 | ||
Change | -$0.17 (-7.76%) | ||
Open | $2.02 | ||
High | $2.16 | ||
Low | $1.97 | ||
Previous Close | $2.19 | ||
Volume | 935,815 | ||
30-Day Average Volume | 827,261 | ||
1-Week Change | 0.50% | ||
1-Month Change | -34.42% | ||
1-Year Change | -57.65% | ||
3-Year Change | -70.47% | ||
5-Year Change | -48.34% | ||
Fundamentals | |||
Shares Outstanding | 61.6M | ||
Total Assets | $197.8M | ||
Market Cap | $124.5M | ||
Enterprise Value | $88.7M | ||
Period: QTR TTM FY | |||
Revenue | $3.2M | ||
Net Income | -$24.5M | ||
Free Cash Flow | -$25.8M | ||
EBIT | -$24.5M | ||
EBITDA | -$23.5M | ||
Net Working Capital | $108.5M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue